focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
The profits are not just from Covid tests. See figures below from today's RNS.
(1) The PCR tests launching in May 2020 at an estimated price of £8-10 per test. GDR currently have materials to make 6 million tests. Gross profit margin of at least 60%. Taking the lower estimate of £8 x 6 million = £48 million - 60% of that = £29m profit.
(2) In December 2020, GDR will launch POC tests for £20 per test, with similar 60% profit margin.
(3) WHO Prequalification for its HCV-ID Kit. genedrive has distribution agreements in place with Sysmex in Europe, Africa and Asia (excluding India) and Arkray in India.
(4) Antibiotic-Induced Hearing Loss. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive® unit and £35 per test.
This is all excluding any news to come - such as increase in manufacturing capacity, FDA approval etc.
The RNS from yesterday (WHO news), sent the SP up to £3 this morning. That RNS is still what it is. No reason why serious investors won’t come back in.
If that RNS didn’t land today then SP may well have risen well above £3. Then if they issued placing tomorrow 7am we would all have been even more annoyed as 80p would be fraction of the £3+ SP.
I just think RNS should have been either yesterday evening or this morning.
When they posted yesterday’s RNS they would have known there was another one coming immediately after.
Looking at ‘Shareholders’ section of Genedrive website is interesting. BGF Investments already has huge holding and have now increased their holding through placing. The only positive news out of this placing is more institutional investor money going in
I doubt that. If you sell and then can only buy a handful of shares at 80p that would be pointless.
Looks like shares will be admitted to market on 28 May 2020. That is approximately when CE mark obtained for tests.
All very sneaky - share price will be at its highest around end of this month